Multimodal Therapy Achieves Secondary Prevention LDL-C Targets in LDL-Receptor Null Homozygous Familial Hypercholesterolemia. [PDF]
Alkhairy A +4 more
europepmc +1 more source
Long-term safety and effectiveness of evinacumab in people with homozygous familial hypercholesterolemia: a plain language summary. [PDF]
Gaudet D +18 more
europepmc +1 more source
Population Pharmacokinetics and Exposure-Response Modeling for Evinacumab in Children, Adolescents, and Adults With Homozygous Familial Hypercholesterolemia. [PDF]
Bihorel S +8 more
europepmc +1 more source
Outpatient monthly plasmapheresis with post-PLEX evinacumab in pediatric homozygous familial hypercholesterolemia: a case report on port access and immunoglobulin preservation. [PDF]
Filler G, Norozi K.
europepmc +1 more source
A Personalized Medicine Approach is Best for Patients with Homozygous Familial Hypercholesterolemia. [PDF]
Morales A +4 more
europepmc +1 more source
Liver transplantation for homozygous familial hypercholesterolemia: a retrospective analysis from Chinese experience. [PDF]
Zhan HS +12 more
europepmc +1 more source
Homozygous Familial Hypercholesterolemia (le).
P R, Somwanshi, N S, Agarwal
openaire +1 more source
Comparison of Model-Predicted and Observed Evinacumab Pharmacokinetics and Efficacy in Children Aged < 5 Years With Homozygous Familial Hypercholesterolemia. [PDF]
Bihorel S +18 more
europepmc +1 more source

